Who
James Joseph Martin
Co-CEO and CFO
Company insider
Files Form 4 as: Co-CEO and CFO, Cocrystal Pharma; Director, PetVivo Holdings; Chief Financial Officer, Vaporin; Chief Financial Officer, Non Invasive Monitoring Systems Inc /fl/; Chief Financial Officer, SafeStitch Medical.
In numbers
- Trades disclosed
- 21
- Buys
- 2
- Sells
- 0
- Bought
- $24K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 10 Mar 2011
- Last trade
- 9 Jan 2026
- Last filed
- 13 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 13 Jan 2026 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,229 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,229 at $0.00 | filing |
| 28 Oct 2025filed 30 Oct 2025 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | $10K7,196 at $1.39 | filing |
| 28 Oct 2025filed 30 Oct 2025 | COCP Cocrystal PharmaBiotechnology | SEC FORM 4 Code A | $5,0013,598 at $1.39 | filing |
| 9 Oct 2024filed 11 Oct 2024 | COCP Cocrystal PharmaBiotechnology | SEC FORM 4 Code A | —40,000 | filing |
| 18 Jul 2023filed 20 Jul 2023 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 Jul 2022filed 3 Aug 2022 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 16 Jul 2021filed 20 Jul 2021 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 24 Apr 2021filed 26 May 2021 | PetVivo HoldingsMedical Devices | SEC FORM 4 Bought | $21K3,000 at $7.00 | filing |
| 12 Mar 2021filed 5 Apr 2021 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code X | —3,447 at $0.00 | filing |
| 12 Mar 2021filed 5 Apr 2021 | PetVivo Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code X | —1,103 at $0.00 | filing |
| 12 Mar 2021filed 5 Apr 2021 | PetVivo Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code X | —1,227 at $0.00 | filing |
| 12 Mar 2021filed 5 Apr 2021 | PetVivo Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code X | —1,117 at $0.00 | filing |
| 22 Jun 2020filed 24 Jun 2020 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 21 Sep 2018filed 24 Sep 2018 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 4 Mar 2015filed 6 Mar 2015 | Vaporin | SEC FORM 4 Code D | —100,600 | filing |
| 24 Oct 2014filed 28 Oct 2014 | Vaporin | SEC FORM 4 Code A | —100,000 | filing |
| 15 Aug 2014filed 18 Aug 2014 | Non Invasive Monitoring Systems Inc /fl/ | SEC FORM 4 Bought | $2,75025,000 at $0.11 | filing |
| 23 Apr 2013filed 25 Apr 2013 | SafeStitch Medicaloption or derivative | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 16 Feb 2012filed 17 Feb 2012 | SafeStitch Medicaloption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.